Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. April 2017 13:45 ET | Quelle: International Society for Heart & Lung Transplantation

MEDAMACS 1-YEAR STUDY RESULTS ON ADVANCED HEART FAILURE INDICATE CLINICIANS SHOULD EXPAND VAD THERAPY TO THOSE PREVIOUSLY THOUGHT AS ‘TOO HEALTHY’

San Diego, April 08, 2017 (GLOBE NEWSWIRE) -- Today researchers presented findings of the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) study, a multi-center, U.S.-based study,...
05. April 2017 14:35 ET | Quelle: International Society for Heart & Lung Transplantation

ENDURANCE SUPPLEMENTAL ONE-YEAR HVAD RESULTS SHOW DECREASED RATE OF STROKE COMPARED TO ENDURANCE TRIAL

San Diego, April 05, 2017 (GLOBE NEWSWIRE) -- Today, during the opening plenary session of the 37TH Annual International Society for Heart and Lung Transplantation (ISHLT) Meeting & Scientific...
24. Juni 2014 21:19 ET | Quelle: Mesoblast

Improved Outcomes Using Mesoblast Cells in End-Stage Heart Failure

NEW YORK and MELBOURNE, Australia, June 24, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB, USOTC: MBLTY) today announced that trial results evaluating a low dose...